Evidence map›Paper›PMID 41644679›Full record

ArticleNPJ digital medicine2026

Scaling medical device regulatory science using large language models.

Hanyang Li, Xiao He, Adarsh Subbaswamy, Patrick Vossler, Alexej Gossmann, Karandeep Singh, Jean Feng

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hanyang Li *Unaffiliated, San Francisco, California, CA, USA.
Xiao He *Unaffiliated, San Francisco, California, CA, USA.
Adarsh SubbaswamyUniversity of Maryland, Baltimore, MD, USA.
Patrick VosslerUniversity of California, San Francisco, CA, USA.
Alexej GossmannUnaffiliated, Annandale, VA, USA.
Karandeep SinghUniversity of California, San Diego, CA, USA.
Jean FengUniversity of California, San Francisco, CA, USA. jean.feng@ucsf.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in artificial intelligence (AI) and machine learning (ML) have led to a surge in AI/ML-enabled medical devices, posing new challenges for regulators because best practices for developing, testing, and monitoring these devices are still emerging. Consequently, there is a critical need for up-to-date data analyses of the regulatory landscape to inform policy-making. However, such analyses have historically relied upon manual annotation efforts because regulatory documents are unstructured, complex, multi-modal, and filled with jargon. Efforts to automate annotation using simple natural language processing methods have achieved limited success, as they lack the reasoning needed to interpret regulatory materials. Recent progress in large language models (LLMs) presents an unprecedented opportunity to unlock information embedded in regulatory documents. This work conducts the first wide-ranging validation study of LLMs for scaling data analyses in the field of medical device regulatory science. Evaluating LLM outputs using expert manual annotations and "LLM-as-a-judge," we find that LLMs can accurately extract attributes spanning pre- and post-market settings, with accuracy rates often reaching 80% or higher. We then demonstrate how LLMs can scale up analyses in three applications: (1) monitoring device validation practices, (2) coding medical device reports, and (3) identifying potential risk factors for post-market adverse events.

Identifiers

PMID41644679
PMCPMC12992660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.